Bijuva is worth clarifying up front, because it comes up alongside peptide conversations even though it is not a peptide. It is a hormone therapy. The two ingredients, estradiol and progesterone, are steroid hormones, not peptide compounds, and that distinction changes almost everything about how you find, price, and evaluate it.
If you are comparing legal, prescription-based providers, the good news is that this category is more settled than the investigational peptide space. Here is what you can actually act on.
The regulatory status is clear
Bijuva is a brand-name product approved by the FDA as a single capsule containing estradiol and progesterone. That approval matters. It means the product went through the standard drug review process and is sold as a finished, manufactured medication rather than as something mixed to order.
This is a different situation from many peptides discussed on this site, which remain investigational and are not FDA approved as finished drugs. With an approved combination product, you are dealing with a defined formulation, a package insert, and a manufacturer standing behind it.
How it reaches you legitimately
An approved brand product like Bijuva is dispensed through ordinary retail and mail-order pharmacies once a licensed clinician writes a prescription. You do not need a specialty compounding pharmacy to obtain the branded capsule itself.
Compounding enters the picture separately. Some clinicians prescribe custom-compounded estradiol and progesterone preparations through 503A or 503B pharmacies. Compounded hormone therapy is legal when prepared for an individual patient under a valid prescription, but it is not the same thing as the FDA-approved Bijuva capsule, and it is not reviewed the same way. If a provider offers a compounded version, ask directly whether you are getting the approved product or a compounded alternative, and why.
What drives the cost
For a branded product, price is shaped by a few concrete factors. Whether your insurance formulary covers the brand is usually the biggest one. When a plan prefers generics or separate single-ingredient hormones, the combination capsule can cost more out of pocket even though it is one item.
Other drivers include the pharmacy you use, manufacturer discount programs, and whether a clinician prescribes the brand or an equivalent set of separate hormones. Compounded preparations are priced differently again, often as a cash service, so a low sticker price there is not automatically a savings once you account for what you are actually receiving.
How to vet a provider
The signals that matter here are the same ones that matter across prescription care. Look for a licensed clinician who takes a history, reviews your medical background, and is willing to discuss why a specific formulation is being recommended over alternatives.
- Confirm the prescriber is licensed in your state and that a real evaluation happens before anything is prescribed.
- Ask whether you are getting the FDA-approved product or a compounded preparation, and get a clear reason for the choice.
- Check that the dispensing pharmacy is a licensed operation, not a research-use-only vendor.
- Ask how follow-up and questions are handled after the first prescription.
A provider who explains trade-offs and answers plainly is doing their job. One that pushes a single product without discussion, or sells around the prescription requirement, is not.
The bottom line
Bijuva sits in the well-mapped territory of approved hormone therapy, which makes it easier to compare than investigational peptides. Focus on coverage, on whether you are getting the branded or compounded version, and on the credentials behind the prescription.
This is general information, not medical advice. Decisions about menopause symptom management, hormone therapy, and any specific product belong between you and a licensed clinician who knows your history.